5 Firms Guide $834M Chinese Biopharma SPAC Merger

By Renee Hickman (September 29, 2022, 10:26 PM EDT) -- Beijing-based biopharmaceutical company Yisheng Biopharma Co. Ltd., announced on Thursday that it will merge with Hong Kong-based blank-check company Summit Healthcare Acquisition Corp. in a transaction that values the new company at $834 million....

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.

  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!


Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!